Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
Annals of the rheumatic diseases, 2009 - ard.bmj.com
Background and objectives: Rheumatoid arthritis (RA) causes considerable disability and
often results in loss of work capacity and productivity. This study evaluated the impact of …
often results in loss of work capacity and productivity. This study evaluated the impact of …
[PDF][PDF] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - Ann Rheum Dis, 2009 - researchgate.net
Background and objectives: Rheumatoid arthritis (RA) causes considerable disability and
often results in loss of work capacity and productivity. This study evaluated the impact of …
often results in loss of work capacity and productivity. This study evaluated the impact of …
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi… - Annals of the Rheumatic …, 2009 - search.proquest.com
Methods: Data from an open-label extension study (DE033) of 486 RA patients receiving
adalimumab monotherapy who previously did not respond to at least one disease-modifying …
adalimumab monotherapy who previously did not respond to at least one disease-modifying …
[引用][C] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT HALPERN, MA CIFALDI… - Annals of the rheumatic …, 2009 - pascal-francis.inist.fr
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label
extension study and a registry-based control group CNRS Inist Pascal-Francis CNRS …
extension study and a registry-based control group CNRS Inist Pascal-Francis CNRS …
Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - Annals of the Rheumatic Diseases, 2008 - ard.bmj.com
Objectives: Rheumatoid arthritis (RA) causes significant disability and often results in loss of
work capacity and productivity. We evaluated the impact of adalimumab, a tumour necrosis …
work capacity and productivity. We evaluated the impact of adalimumab, a tumour necrosis …
[引用][C] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
H MT - Ann Rheum Dis, 2009 - cir.nii.ac.jp
Impact of adalimumab on work participation in rheumatoid arthritis : comparison of an open-label
extension study and a registry-based control group | CiNii Research CiNii 国立情報学研究所 …
extension study and a registry-based control group | CiNii Research CiNii 国立情報学研究所 …
[HTML][HTML] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - Annals of the Rheumatic …, 2009 - ncbi.nlm.nih.gov
Methods: Data from an open-label extension study (DE033) of 486 RA patients receiving
adalimumab monotherapy who previously did not respond to at least one disease-modifying …
adalimumab monotherapy who previously did not respond to at least one disease-modifying …
[PDF][PDF] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - Ann Rheum Dis, 2009 - academia.edu
Background and objectives: Rheumatoid arthritis (RA) causes considerable disability and
often results in loss of work capacity and productivity. This study evaluated the impact of …
often results in loss of work capacity and productivity. This study evaluated the impact of …
[PDF][PDF] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - 2008 - Citeseer
Objectives: Rheumatoid arthritis (RA) causes significant disability and often results in loss of
work capacity and productivity. We evaluated the impact of adalimumab, a tumour necrosis …
work capacity and productivity. We evaluated the impact of adalimumab, a tumour necrosis …
[PDF][PDF] Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group
MT Halpern, MA Cifaldi, TK Kvien - Ann Rheum Dis, 2009 - scienceopen.com
Background and objectives: Rheumatoid arthritis (RA) causes considerable disability and
often results in loss of work capacity and productivity. This study evaluated the impact of …
often results in loss of work capacity and productivity. This study evaluated the impact of …